Diabetes mellitus tipo 2 y su nueva terapia farmacológica y no farmacológica, revisión de la bibliografía

Abstract

Introduction: Type 2 Diabetes Mellitus (T2DM) is a chronic disease affecting an increasing proportion of the global population. Proper management of T2DM is essential to prevent severe complications, including cardiovascular disease and kidney damage. Objective: This article reviews existing literature on new pharmacological and nonpharmacological therapies for the treatment of T2DM. Methodology: A literature review was conducted using various academic databases to identify recent studies and trials exploring new pharmacological and non-pharmacological therapies for T2DM. Results: Several new pharmacological therapies were identified, including new hypoglycemic agents, as well as non-pharmacological approaches that include dietary changes, exercise, and lifestyle modifications. The efficacy of these treatments varied, but several showed promise in improving glycemic control and reducing the risk of complications. In addition, some therapies also demonstrated benefits in terms of weight loss and improvement of cardiovascular risk factors. Conclusions: The new pharmacological and non-pharmacological therapies for T2DM may provide additional and effective treatment options for patients. However, an individualized assessment is essential to select the most suitable therapy for each patient based on their clinical profile and preferences. The findings also suggest that more research is needed to establish the long-term effectiveness and safety of these new therapies, as well as to investigate potential new treatment options.